BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 33778834)

  • 21. Inhibitor of growth 4 (ING4) inhibits hypoxia-induced EMT by decreasing HIF-1α and snail in HK2 cells.
    Lu L; Li J; Le Y; Jiang H
    Acta Histochem; 2019 Aug; 121(6):695-703. PubMed ID: 31239073
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Correlation between bacterial L-form infection, expression of HIF-1α/MMP-9 and vasculogenic mimicry in epithelial ovarian cancer].
    Yu L; Wu SW; Zhou L; Song WQ
    Sheng Li Xue Bao; 2012 Dec; 64(6):657-65. PubMed ID: 23258329
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Loss of VHL expression contributes to epithelial-mesenchymal transition in oral squamous cell carcinoma.
    Zhang S; Zhou X; Wang B; Zhang K; Liu S; Yue K; Zhang L; Wang X
    Oral Oncol; 2014 Sep; 50(9):809-17. PubMed ID: 24998140
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HDAC2 promotes cell migration/invasion abilities through HIF-1α stabilization in human oral squamous cell carcinoma.
    Chang CC; Lin BR; Chen ST; Hsieh TH; Li YJ; Kuo MY
    J Oral Pathol Med; 2011 Aug; 40(7):567-75. PubMed ID: 21332579
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HIF-1alpha is a prognostic marker in oral squamous cell carcinomas.
    Eckert AW; Schutze A; Lautner MH; Taubert H; Schubert J; Bilkenroth U
    Int J Biol Markers; 2010; 25(2):87-92. PubMed ID: 20544685
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hypoxia enhances CXCR4 expression by activating HIF-1 in oral squamous cell carcinoma.
    Ishikawa T; Nakashiro K; Klosek SK; Goda H; Hara S; Uchida D; Hamakawa H
    Oncol Rep; 2009 Mar; 21(3):707-12. PubMed ID: 19212630
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Expression of RACK1 and EGP40 in oral squamous cell carcinoma and its correlation with clinicopathological features and prognosis].
    Duan YH; Wu KL; Mei J; Zhou YY; Liu MS
    Shanghai Kou Qiang Yi Xue; 2023 Aug; 32(4):385-390. PubMed ID: 38044732
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hypoxia inducible factor-1α expression in areca quid chewing-associated oral squamous cell carcinomas.
    Lee SS; Tsai CH; Yang SF; Ho YC; Chang YC
    Oral Dis; 2010 Oct; 16(7):696-701. PubMed ID: 20846156
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Expression and clinical significance of MTDH, HIF-1α and TKTL1 in laryngeal carcinoma].
    Jia X; Shan C; Xu O; Wang J
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2015 Dec; 29(24):2133-8. PubMed ID: 27093812
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transcutaneous carbon dioxide suppresses epithelial-mesenchymal transition in oral squamous cell carcinoma.
    Iwata E; Hasegawa T; Takeda D; Ueha T; Kawamoto T; Akisue T; Sakai Y; Komori T
    Int J Oncol; 2016 Apr; 48(4):1493-8. PubMed ID: 26846904
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of the expression of TGF-β1, E-cadherin, N-cadherin, TP53, RB1CC1 and HIF-1α in oral squamous cell carcinoma and lymph node metastases of humans and mice.
    Guo M; Mu Y; Yu D; Li J; Chen F; Wei B; Bi S; Yu J; Liang F
    Oncol Lett; 2018 Feb; 15(2):1639-1645. PubMed ID: 29399192
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Expression of hypoxia-inducible factor-1alpha and vessel endothelial growth factor in esophageal squamous cell carcinoma and clinico-pathological significance thereof].
    Yu ZT; Zhao HF; Shang XB
    Zhonghua Yi Xue Za Zhi; 2008 Sep; 88(35):2465-9. PubMed ID: 19080625
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Significance of HIF-1α Expression and LOXL-2 Localization in Progression of Oral Squamous Cell Carcinoma.
    Bharti A; Urs AB; Kumar P
    Asian Pac J Cancer Prev; 2021 Feb; 22(2):341-347. PubMed ID: 33639646
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Key proteins of invadopodia are overexpressed in oral squamous cell carcinoma suggesting an important role of MT1-MMP in the tumoral progression.
    Mitre GP; Balbinot KM; Ribeiro ALR; da Silva Kataoka MS; de Melo Alves Júnior S; de Jesus Viana Pinheiro J
    Diagn Pathol; 2021 Apr; 16(1):33. PubMed ID: 33879222
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The new tumor-suppressor gene inhibitor of growth family member 4 (ING4) regulates the production of proangiogenic molecules by myeloma cells and suppresses hypoxia-inducible factor-1 alpha (HIF-1alpha) activity: involvement in myeloma-induced angiogenesis.
    Colla S; Tagliaferri S; Morandi F; Lunghi P; Donofrio G; Martorana D; Mancini C; Lazzaretti M; Mazzera L; Ravanetti L; Bonomini S; Ferrari L; Miranda C; Ladetto M; Neri TM; Neri A; Greco A; Mangoni M; Bonati A; Rizzoli V; Giuliani N
    Blood; 2007 Dec; 110(13):4464-75. PubMed ID: 17848618
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinical research on the expression of three vascular regulatory factors in different morphological regions of Marjolin ulcer and their relationship with angiogenesis].
    Xia C; Chu ZG
    Zhonghua Shao Shang Za Zhi; 2019 Sep; 35(9):676-682. PubMed ID: 31594186
    [No Abstract]   [Full Text] [Related]  

  • 37. Hypoxia-inducible factor-1alpha polymorphisms and TSC1/2 mutations are complementary in head and neck cancers.
    Hebert C; Norris K; Parashar P; Ord RA; Nikitakis NG; Sauk JJ
    Mol Cancer; 2006 Jan; 5():3. PubMed ID: 16412252
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The involvement of hypoxia-inducible factor-1alpha in the susceptibility to gamma-rays and chemotherapeutic drugs of oral squamous cell carcinoma cells.
    Sasabe E; Zhou X; Li D; Oku N; Yamamoto T; Osaki T
    Int J Cancer; 2007 Jan; 120(2):268-77. PubMed ID: 17066447
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Correlation of expression of hypoxia-related proteins with prognosis in oral squamous cell carcinoma patients.
    Eckert AW; Kappler M; Schubert J; Taubert H
    Oral Maxillofac Surg; 2012 Jun; 16(2):189-96. PubMed ID: 22592457
    [TBL] [Abstract][Full Text] [Related]  

  • 40. TMEM207 hinders the tumour suppressor function of WWOX in oral squamous cell carcinoma.
    Bunai K; Okubo H; Hano K; Inoue K; Kito Y; Saigo C; Shibata T; Takeuchi T
    J Cell Mol Med; 2018 Feb; 22(2):1026-1033. PubMed ID: 29164763
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.